Lavaca Capital’s STAAR Surgical STAA Stock Holding History

Lavaca Capital’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-5,277	Closed	-$180K	–	317
2019 Q1	$180K	Buy	+5,277	New	+$187K	0.15%	71

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Lavaca Capital's STAA Position: Q2 2019 in Review

Lavaca Capital sold out of STAAR Surgical (STAA) in Q2 2019, closing a stake of 5,277 shares — an estimated $180K sold.

Lavaca Capital first reported a position in STAA in Q1 2019 and held it in 1 quarter. The position peaked at $180K in Q1 2019. 155 funds tracked by Wall St. Rank hold STAA as of Q2 2019.

Lavaca Capital reported no remaining STAAR Surgical position as of Q2 2019 after selling out during the quarter.
Lavaca Capital sold 5,277 STAAR Surgical shares in Q2 2019, an estimated $180K.
Lavaca Capital first reported a position in STAAR Surgical in Q1 2019 and held it in 1 quarter.
Lavaca Capital's STAAR Surgical position peaked at $180K in Q1 2019.
155 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2019.

Based on Lavaca Capital's 13F filing for Q2 2019, filed 29 Jul 2019.